glp-1 prescriptions growth slowdown 2024 Are Up, Health Services Utilization Down, and GLP-1s Are a Major Driver: IQVIA's Update GLP-1 Receptor Agonist Market Forecast
Description
Therefore, we hypothesise that a combination of pancreatic GLP-1 and GIP is necessary for the full effect of DPP-4 inhibitors on glucose homeostasis
The body requires signals to determine which tissue to keep and which tissue to lose
Mendonca, L., Moura, H., Chaves, P
Allen, T
, 24 [21]
